Publication | Closed Access

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Treatment And PreventionMedicineFirst-line Antiretroviral TherapyClinical TrialsAntiviral Drug DevelopmentVirologyAntiviral TherapyPharmacotherapyAntiviral DrugHivRandomised Open-label TrialPharmacology